Wednesday, February 1, 2023
HomeMarketModerna Inc. stock underperforms Tuesday when compared to competitors despite daily gains

Moderna Inc. stock underperforms Tuesday when compared to competitors despite daily gains

- Advertisement -

Shares of Moderna Inc.
MRNA,
+1.61%
rose 1.61% to $179.59 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index
COMP,
+1.36%
rising 1.36% to 11,174.41 and the Dow Jones Industrial Average
DJIA,
+1.18%
rising 1.18% to 34,098.10. The stock’s rise snapped a four-day losing streak. Moderna Inc. closed $197.06 below its 52-week high ($376.65), which the company achieved on November 29th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as AbbVie Inc.
ABBV,
+1.71%
rose 1.71% to $159.79, Amgen Inc.
AMGN,
-0.39%
fell 0.39% to $287.05, and AstraZeneca PLC ADR
AZN,
+0.87%
rose 0.87% to $66.00. Trading volume (3.3 M) remained 1.8 million below its 50-day average volume of 5.1 M.


Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Credit: marketwatch.com

RELATED ARTICLES
- Advertisment -

Most Popular